Form 4: Quest Diagnostics CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Quest Diagnostics CEO, James E. Davis, disposed of 2,966 shares of common stock to cover tax withholding obligations arising from the vesting of restricted stock units on February 26, 2025.
Summary
- On February 26, 2025, James E. Davis, the CEO and President of Quest Diagnostics Inc., disposed of 2,966 shares of common stock.
- The transaction was executed to cover tax withholding obligations related to the vesting of restricted stock units.
- The shares were disposed of at a price of $171.75 per share.
- Following the transaction, Davis directly owns 138,215 shares of Quest Diagnostics Inc.
- The transaction was reported on February 28, 2025.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations, with no inherent positive or negative implications for the company's performance.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. They can be influenced by various factors, including personal financial planning, diversification, and compliance with company policies. It's typical for executives to sell shares to cover tax obligations arising from the vesting of stock awards.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on shareholders, as it is a routine sale of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/26/2025 | Date of transaction: Disposition of common stock to cover tax withholding obligations. |
| 02/28/2025 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.